Cite
HARVARD Citation
Chanan-Khan, A. et al. (n.d.). Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Lancet oncology. 17 (2), pp. 200-211. [Online].